Product Information
CHILDREN IBUPROFEN 100 MG/5 ML is a generic product labeled by Camber Consumer Care, priced at $0.0320 per ML under NDC 69230030912. Its NADAC has been published 198 times since Dec 21, 2022.
FDA first approved this application on Nov 23, 2018.
Strength
100 mg/5mL
Manufacturer
Camber Consumer CareNDC
69230030912
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA210602FDA Approved
11/23/2018
On Market Since
9/18/2019
Pharmacological Classes
Price Statistics
The NADAC for CHILDREN IBUPROFEN 100 MG/5 ML has been published 198 times since Dec 21, 2022, and over the history we have for it it has risen 25.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0320 per ML |
|---|---|
| All-time high | $0.0320 (Sep 30, 2026) |
| All-time low | $0.0249 (Jun 21, 2023) |
| 52-week high | $0.0320 |
| 52-week low | $0.0303 |
| Median price | $0.0306 |
| Average price | $0.0297 |
| Largest weekly change | +24.5% (Sep 20, 2023) |
| Weeks tracked | 198 |
| Tracking since | Dec 21, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 23% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Consumer Care manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ibuprofen Oral market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHILDREN IBUPROFEN 100 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for CHILDREN IBUPROFEN 100 MG/5 ML, manufactured by Camber Consumer Care, is $0.0320 per ML (NDC 69230030912), effective Sep 30, 2026.
How has the price of CHILDREN IBUPROFEN 100 MG/5 ML changed over time?
Over the history we have for it, the NADAC for CHILDREN IBUPROFEN 100 MG/5 ML has risen 25.3%. It has been tracked across 198 weekly CMS publications since Dec 21, 2022.
What are the highest and lowest recorded NADAC prices for CHILDREN IBUPROFEN 100 MG/5 ML?
Since Dec 21, 2022, the NADAC for CHILDREN IBUPROFEN 100 MG/5 ML has ranged from a low of $0.0249 (Jun 21, 2023) to a high of $0.0320 (Sep 30, 2026), with a median of $0.0306 per ML.
Are there cheaper alternatives to CHILDREN IBUPROFEN 100 MG/5 ML?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 100 MG/5 ML SUSP, is $0.0246 per ML — about 23% below CHILDREN IBUPROFEN 100 MG/5 ML.
Who manufactures CHILDREN IBUPROFEN 100 MG/5 ML?
CHILDREN IBUPROFEN 100 MG/5 ML (NDC 69230030912) is labeled by Camber Consumer Care, and CMS classifies it as a generic product.